Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Xarelto Dry Syrup Now Available in Japan: Bayer
July 13, 2021
- Astellas/Seagen’s ADC Padcev Snags Full Approval, Label Expansion
July 13, 2021
- Sanofi/GSK COVID-19 Vaccine Enters PIII in Japan
July 13, 2021
- Teijin Restricting Shipments for Onealfa after Curbs on Edirol
July 13, 2021
- Towa’s Shipment Control List Expands to 241 Products; 7 Added
July 13, 2021
- Pfizer R&D, NTT Data to Collaborate with NCC for Efficient Clinical Research
July 12, 2021
- Enhertu PIII Begins for 2nd Line Use in HER2-Positive Gastric Cancer
July 12, 2021
- Chugai, Alebund Ink Option and License Pact for Hyperphosphatemia Drug
July 12, 2021
- Otsuka Files Auto-Injector Version of Migraine Drug Ajovy
July 9, 2021
- 1,600 Vaccine Doses Ruined at Chugai Due to Flawed Temperature Control
July 9, 2021
- Fueled by Roivant Deal, Sumitomo Dainippon Accelerating DX as It Looks Beyond Latuda LOE
July 9, 2021
- FDA Updates Aduhelm Label to Only Cover MCI, Mild Alzheimer’s
July 9, 2021
- KM Biologics Expects PIII Launch for COVID-19 Vaccine This Autumn: President
July 8, 2021
- Edirol, Generic Drugs All Now Face Supply Curbs as Nichi-Iko Woes Spill Over
July 8, 2021
- Bristol Myers Kicks Off COVID-19 Inoculation Program, Eliminates Cost Burden on Employees
July 8, 2021
- Tecentriq Filed in Japan as Adjuvant Therapy for NSCLC: Chugai
July 8, 2021
- Bayer’s Vitrakvi Now Available in Japan for NTRK-Positive Solid Tumors
July 8, 2021
- Japan Ethical Drug Sales Up 6.8% in May: Crecon
July 8, 2021
- 34 Japan Pharma Execs Earn 100 Million Yen or More in FY2020, Top 3 at Takeda
July 7, 2021
- 26 Japan Drug Makers’ Annual Pay Averages 8.21 Million Yen, 5 Firms Top 10 Million Yen Mark
July 7, 2021
ページ
More than a year after Dupixent (dupilumab) became the first antibody therapy approved for COPD in Japan, drug makers are…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…